Lumendi news

The latest news about Lumendi

EZ¹ successfully completes Customer Evaluation phase.

Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading EZ¹ successfully completes Customer Evaluation phase.

A Randomized Prospective Study Evaluating Effectiveness Of A Double Balloon Endolumenal Platform For Colorectal EndoscopicSubmucosal Dissection

Endoscopic removal of colonic polyps and early cancers eliminates the need for surgical resection and possible temporary or permanent colostomy.

Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE

Award for the Balloon Endo-Luminal Lumen Occluding (BELLO) Device Presented to Dr. Maselli at the ESGE Days 2023 Congress Apr 20, 2023, 12:27 ET Lumendi Congratulates Dr. Maselli on the… Continue reading Dr. Roberta Maselli, receives innovation of the year award for the best new device from the ESGE

Lumendi Receives 510(k) Clearance for Two New Devices

Lumendi, LLC has received U.S. Food and Drug Administration (FDA) 510(k) clearance for DiLumen EZ¹, a single-use, disposable endotherapy device for endoscopic mucosal resections (EMR) and difficult colonoscopies.

Expansion of the Dilumen Platform

DiLumen EZ¹ The DiLumen EZ¹ is a variant of the DiLumen design, specially intended for the removal of complex polyps using the EMR* technique. Thanks to its unique balloon design,… Continue reading Expansion of the Dilumen Platform

Lumendi Files for 510(k) Clearance for Two New Products

Company Achieves New Milestone with 3,000 Therapeutic Procedures Completed Across U.S., Europe, and Asia Using DiLumen™ EIP DiLumen EZ¹ single balloon stabilization endotherapy device. (Photo: Business Wire) May 19, 2022… Continue reading Lumendi Files for 510(k) Clearance for Two New Products

A successful Digestive Disease Week (DDW) conference in San Diego

Since the company’s inception, we have accumulated over 100 DiLumen users worldwide. Half of these physicians have begun using our devices in the last 12 to 18 months. This year’s DDW was our first opportunity in three years to present Lumendi and our significantly enhanced DiLumen platform to users and industry.

DiLumen EIP is now even easier to use with EZ-Glide hydrophilic coating

DiLumen EZ-Glide improves visibility and simplifies intraoperative